Amaç: Bu çalışma, baş-boyun kanserli hastalarda geleneksel ve tamamlayıcı tedavi (GETAT) kullanım oranını, kullanılan maddeleri, hastaların sosyodemografik ve klinik özellikleriyle GETAT kullanımı arasındaki ilişkiyi değerlendirmek için yapılmıştır. Gereç ve Yöntemler: Tanımlayıcı olarak yapılan araştırma, kulak-burun-boğaz hastalıkları polikliniğinde baş-boyun kanseri nedeniyle takip edilen 51 hastayla tamamlanmıştır. Literatürün incelenmesi sonucu oluşturulan anket formu, yüz yüze görüşme yöntemiyle doldurulmuştur. Verilerin analizi 'Statistical Software Package for the Social Sciences (SPSS)' 22.0 istatistik paket programı ile yapılmıştır. İstatistiksel anlamlılık düzeyi p<0,05 alınmıştır. Bulgular: Hastaların %94,1 (n=48)'i erkek iken, %5,9 (n=3)'u kadındır. Katılımcıların yaş aralığı 35-72 arasında değişirken; ortalaması 60,6±8,6'dır. Hastaların %54,9'u ilkokul mezunu iken sadece %9,8'i üniversite mezunudur. On iki hasta (%23,5) GETAT kullanmıştır. En sık %16,7 ile ısırgan otu (fitoterapi) kullanılmıştır. Bal ve propolis, diğer sık kullanılan (%16,7) apiterapi ürünleridir. %43,7 oranında kanserle daha iyi savaşabilmek için vücut direncinin artırılması amacıyla kullanıldığı belirtilmiştir. Eğitim ve gelir düzeyine göre GETAT kullanma arasında anlamlı fark saptanmamıştır. Ek hastalığı olmayanlar, istatistiksel olarak anlamlı şekilde daha yüksek sıklıkla GETAT kullanmıştır (p=0,005). Sonuç: Baş-boyun kanserli hastalarda kullanımı yüksek oranlarda görülebilmektedir. Çalışmamızda, en sık bitkisel ve besinsel ürünlerin kullanıldığı görülmüştür. Isırgan otu, literatüre benzer olarak en sık kullanılan fitoterapi üründür. Bal ve propolis ise en sık kullanılan apiterapi ürünleridir.
Anahtar Kelimeler: Baş-boyun kanseri; geleneksel ve tamamlayıcı tedavi; ısırgan otu
Objective: This study was conducted to evaluate the use of traditional and complementary medicine (TCAM) in patients with head and neck cancer and the relationship between the substances used, the sociodemographic and clinical features of the patients. Material and Methods: Descriptive research was completed with 51 patients who were followed up in the otorhinolaryngology outpatient clinic for head and neck cancer. The questionnaire created as a result of the review of the iterature was filled with face to face interview method. Data analysis was performed with Statistical Software Package for the Social Sciences (SPSS) 22.0 statistical package program. Statistical significance level was taken as p<0.05. Results: 94.1% (n=48) of the patients were male, 5.9% (n=3) of the patients were female. While the age range of the participants varied between 35-72 years; the average is 60.6±8.6. While 54.9% of the patients are primary school graduates, only 9.8% are university graduates. Twelve patients (23.5%) used TCAM. Nettle (phytotherapy) was used most frequently with 16.7%. Honey and propolis are other common (16.7%) apitherapy products. It is stated that 43.7% is used to increase body resistance in order to fight cancer better. There was no significant difference between using traditional and complementary medicine according to education and income level. Those without chronic diseases used statistically significantly higher frequency TCAM (p=0.005). Conclusion: The use of TCAM can be seen in high rates in patients with head and neck cancer. In our study, it was seen that the most common phytotherapy and apitherapy products were used. Nettle is the most commonly used phytotherapy product, similar to the literature. Honey and propolis are the most frequently used apitherapy products.
Keywords: Head and neck cancer; traditional and complementary medicine; nettle
- Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;27;(343):1-19. [PubMed]
- Schultz JD, Stegmüller M, Faber A, Thorn C, Hörmann K, Nowack R, et al. Complementary and alternative medications consumed by patients with head and neck carcinoma: a pilot study in Germany. Nutr Cancer. 2012;64(3):377-85. [Crossref] [PubMed]
- Asher BF, Seidman M, Snyderman C. Complementary and alternative medicine in otolaryngology. Laryngoscope. 2001;111(8):1383-9. [Crossref] [PubMed]
- Zuo JJ, Tao ZZ, Chen C, Hu ZW, Xu YX, Zheng AY, et al. Characteristics of cigarette smoking without alcohol consumption and laryngeal cancer: overall and time-risk relation. A meta-analysis of observational studies. Eur Arch Otorhinolaryngol. 2017;274(3):1617-31. [Crossref] [PubMed]
- Hendershot KA, Dixon M, Kono SA, Shin DM, Pentz RD. Patients' perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implications. Complement Ther Clin Pract. 2014;20(4):213-8. [Crossref] [PubMed]
- Brake MK, Bartlett C, Hart RD, Trites JR, Taylor SM. Complementary and alternative medicine use in the thyroid patients of a head and neck practice. Otolaryngol Head Neck Surg. 2011;145(2):208-12. [Crossref] [PubMed]
- Kato I, Neale AV. Does use of alternative medicine delay treatment of head and neck cancer? A surveillance, epidemiology, and end results (SEER) cancer registry study. Head Neck. 2008;30(4):446-54. [Crossref] [PubMed]
- Sullivan A, Gilbar P, Curtain C. Complementary and Alternative medicine use in cancer patients in Rural Australia. Integr Cancer Ther. 2015;14(4):350-8. [Crossref] [PubMed]
- Üstündağ S, Demir Zencirci A. Complementary and alternative medicine use among cancer patients and determination of affecting factors: a questionnaire study. Holist Nurs Pract. 2015;29(6):357-69. [Crossref] [PubMed]
- Gan GG, Leong YC, Bee PC, Chin E, Teh AK. Complementary and alternative medicine use in patients with hematological cancers in Malaysia. Support Care Cancer. 2015;23(8):2399-406. [Crossref] [PubMed]
- Kobya Buluta H, Bektaş M. [Use of complementary medicine in children receiving chemotherapy]. Geleneksel ve Tamamlayıcı Tıp Dergisi. 2019;2(3):106-17. [Crossref]
- Shakeel M, Newton JR, Bruce J, Ah-See KW. Use of complementary and alternative medicine by patients attending a head and neck oncology clinic. J Laryngol Otol. 2008;122(12):1360-4. [Crossref] [PubMed]
- Amin M, Glynn F, Rowley S, O'Leary G, O'Dwyer T, Timon C, et al. Complementary medicine use in patients with head and neck cancer in Ireland. Eur Arch Otorhinolaryngol. 2010;267(8):1291-7. [Crossref] [PubMed]
- Molassiotis A, Ozden G, Platin N, Scott JA, Pud D, Fernandez-Ortega P, et al. Complementary and alternative medicine use in patients with head and neck cancers in Europe. Eur J Cancer Care (Engl). 2006;15(1):19-24. [Crossref] [PubMed]
- Algier LA, Hanoglu Z, Ozden G, Kara F. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey. Eur J Oncol Nurs. 2005;9(2):138-46. [Crossref] [PubMed]
- Gözüm S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs. 2003;26(3):230-6. [Crossref] [PubMed]
- Kav S, Hanoğlu Z, Algier L. Türkiyede kanserli hastalarda tamamlayıcı ve alternatif tedavi yöntemlerinin kullanımı: Literatür taraması [Use of the complementary and alternative medicine by cancer patients in Turkey: literature review]. International Journal of Hematology and Oncology. 2008;18(1):32-8. [Link]
- Wode K, Henriksson R, Sharp L, Stoltenberg A, Hök Nordberg J. Cancer patients' use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med. 2019;13;19(1):62. [Crossref] [PubMed] [PMC]
.: İşlem Listesi